Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,022,521
-
Share change
-
0
-
Total reported value
-
$12,926,000
-
Price per share
-
$6.39
-
Number of holders
-
12
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q4 2013
As of 31 Dec 2013,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,022,521 shares.
The largest 10 holders included
MARXE AUSTIN W & GREENHOUSE DAVID M, SABBY MANAGEMENT, LLC, GROW Partners, LLC, GRANITE POINT CAPITAL MANAGEMENT, L.P., BARD ASSOCIATES INC, SCOGGIN LLC, DAFNA Capital Management LLC, SPRINGBOK CAPITAL MANAGEMENT, LLC, SOPHROSYNE CAPITAL LLC, and Geduld E E.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.